Country: United States
Language: English
Source: NLM (National Library of Medicine)
CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB), PREVITAMIN D3 (UNII: HDA46400N5) (PREVITAMIN D3 - UNII:HDA46400N5), MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838), ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z), SODIUM BORATE (UNII: 91MBZ8H3QO) (BORATE ION - UNII:44OAE30D22)
Bayer HealthCare LLC.
CALCIUM CARBONATE
CALCIUM CARBONATE 500 mg
ORAL
OTC DRUG
Export only
CALCEMIN ADVANCE- CALCIUM CITRATE TABLET, FILM COATED BAYER HEALTHCARE LLC. ---------- CALCEMIN ADVANCE DRUG FACTS DRUG FACTS CALCEMIN ADVANCE calcium citrate tablet, film coated PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:0 28 0 -0 272 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH CALCIUM CARBO NATE (UNII: H0 G9 379 FGK) (CALCIUM CATION - UNII:2M8 3C4R6 ZB) CALCIUM CARBONATE 50 0 mg PREVITAMIN D3 (UNII: HDA46 40 0 N5) (PREVITAMIN D3 - UNII:HDA46 40 0 N5) PREVITAMIN D3 3 mg MAGNESIUM O XIDE (UNII: 3A3U0 GI71G) (MAGNESIUM CATION - UNII:T6 V3LHY8 38 ) MAGNESIUM OXIDE 40 mg ZINC O XIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 7.5 mg SO DIUM BO RATE (UNII: 9 1MBZ8 H3QO) (BORATE ION - UNII:44OAE30 D22) SODIUM BORATE 2.45 mg INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH CRO SCARMELLO SE SO DIUM (UNII: M28 OL1HH48 ) STEARIC ACID (UNII: 4ELV7Z6 5AP) SO DIUM LAURYL SULFATE (UNII: 36 8 GB5141J) HYPRO MELLO SES (UNII: 3NXW29 V3WO) TITANIUM DIO XIDE (UNII: 15FIX9 V2JP) TRIACETIN (UNII: XHX3C3X6 73) MAGNESIUM SILICATE (UNII: 9 B9 6 9 1B2N9 ) MINERAL O IL (UNII: T5L8 T28 FGP) FD&C RED NO . 4 0 (UNII: WZB9 127XOA) FD&C YELLO W NO . 6 (UNII: H77VEI9 3A8 ) FD&C BLUE NO . 1 (UNII: H3R47K3TBD) WATER (UNII: 0 59 QF0 KO0 R) MALTO DEXTRIN (UNII: 7CVR7L4A2D) PRODUCT CHARACTERISTICS COLOR white S CORE no sco re S HAP E OVAL S IZ E 15mm FLAVOR IMPRINT CODE No ne CONTAINS PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:0 28 0 -0 272-30 1 in 1 CARTON 0 4/0 1/20 16 1 30 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct 2 NDC:0 28 0 -0 272-6 0 1 in 1 CARTON 0 4/0 1/20 16 2 6 0 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct 3 NDC:0 28 0 -0 272-12 1 in 1 CARTON 0 4/0 1/20 16 3 120 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct Bayer HealthCare LLC. MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE Expo rt Read the complete document